Physician profile
Marshall D Bailey
NPI 1518377175
$587.84
in general payments reported to CMS, 2019-2025
10 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $167 · 2021: $21.45 · 2022: $116 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.08 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $115.62 | 2022 | |
| Ceribell, INC. | $115.00 | 2025 | Pocket Eeg Device |
| Actelion Pharmaceuticals US, INC. | $89.60 | 2019-2020 | |
| Astellas Pharma US INC | $40.20 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $35.54 | 2019-2020 | |
| Glaxosmithkline, LLC. | $21.60 | 2025 | Nucala |
| Sandoz INC. | $18.94 | 2019 | |
| Genzyme Corporation | $15.05 | 2025 | |
| Merck Sharp & Dohme LLC | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.